 | • レポートコード：D005-00441 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、老年医学の世界市場を広く調査・分析し、今後の市場展望をまとめております。老年医学の種類別市場規模（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）、用途別市場規模（循環器系、関節炎、神経系、がん、骨粗しょう症、呼吸器系）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、AstraZeneca、Bristol-Myers Squibb、Boehringer Ingelheim、Abbott、Novartis、Sanofi S.A.、Eli Lilly、Pfizer、Merck ・地域別グローバル市場分析 2015年-2020年 ・老年医学の北米市場（アメリカ、カナダ、メキシコ） ・老年医学のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・老年医学のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・老年医学の南米市場（ブラジル、アルゼンチン） ・老年医学の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬 ・用途別分析：循環器系、関節炎、神経系、がん、骨粗しょう症、呼吸器系 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Geriatric Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 594790 million by 2025, from USD 511530 million in 2019.
The Geriatric Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Geriatric Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Geriatric Medicine market has been segmented into:
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant
By Application, Geriatric Medicine has been segmented into:
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Geriatric Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Geriatric Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Geriatric Medicine market.
The report offers in-depth assessment of the growth and other aspects of the Geriatric Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Geriatric Medicine Market Share Analysis
Geriatric Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Geriatric Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Geriatric Medicine sales, revenue and market share for each player covered in this report.
The major players covered in Geriatric Medicine are:
GSK
AstraZeneca
Bristol-Myers Squibb
Boehringer Ingelheim
Abbott
Novartis
Sanofi S.A.
Eli Lilly
Pfizer
Merck
Table of Contents
1 Geriatric Medicine Market Overview
1.1 Product Overview and Scope of Geriatric Medicine
1.2 Classification of Geriatric Medicine by Type
1.2.1 Global Geriatric Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Geriatric Medicine Revenue Market Share by Type in 2019
1.2.3 Analgesics
1.2.4 Antihypertensives
1.2.5 Statins
1.2.6 Antidiabetics
1.2.7 Proton Pump Inhibitor
1.2.8 Anticoagulant
1.2.9 Antipsychotic
1.2.10 Antidepressant
1.3 Global Geriatric Medicine Market by Application
1.3.1 Overview: Global Geriatric Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular
1.3.3 Arthritis
1.3.4 Neurological
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Global Geriatric Medicine Market by Regions
1.4.1 Global Geriatric Medicine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Geriatric Medicine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Geriatric Medicine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Geriatric Medicine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Geriatric Medicine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Geriatric Medicine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Geriatric Medicine Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbott SWOT Analysis
2.5.4 Abbott Product and Services
2.5.5 Abbott Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi S.A.
2.7.1 Sanofi S.A. Details
2.7.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi S.A. SWOT Analysis
2.7.4 Sanofi S.A. Product and Services
2.7.5 Sanofi S.A. Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Geriatric Medicine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Geriatric Medicine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Geriatric Medicine Players Market Share
3.2.2 Top 10 Geriatric Medicine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Geriatric Medicine Revenue and Market Share by Regions
4.2 North America Geriatric Medicine Revenue and Growth Rate (2015-2020)
4.3 Europe Geriatric Medicine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Geriatric Medicine Revenue and Growth Rate (2015-2020)
4.5 South America Geriatric Medicine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Geriatric Medicine Revenue and Growth Rate (2015-2020)
5 North America Geriatric Medicine Revenue by Countries
5.1 North America Geriatric Medicine Revenue by Countries (2015-2020)
5.2 USA Geriatric Medicine Revenue and Growth Rate (2015-2020)
5.3 Canada Geriatric Medicine Revenue and Growth Rate (2015-2020)
5.4 Mexico Geriatric Medicine Revenue and Growth Rate (2015-2020)
6 Europe Geriatric Medicine Revenue by Countries
6.1 Europe Geriatric Medicine Revenue by Countries (2015-2020)
6.2 Germany Geriatric Medicine Revenue and Growth Rate (2015-2020)
6.3 UK Geriatric Medicine Revenue and Growth Rate (2015-2020)
6.4 France Geriatric Medicine Revenue and Growth Rate (2015-2020)
6.5 Russia Geriatric Medicine Revenue and Growth Rate (2015-2020)
6.6 Italy Geriatric Medicine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Geriatric Medicine Revenue by Countries
7.1 Asia-Pacific Geriatric Medicine Revenue by Countries (2015-2020)
7.2 China Geriatric Medicine Revenue and Growth Rate (2015-2020)
7.3 Japan Geriatric Medicine Revenue and Growth Rate (2015-2020)
7.4 Korea Geriatric Medicine Revenue and Growth Rate (2015-2020)
7.5 India Geriatric Medicine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Geriatric Medicine Revenue and Growth Rate (2015-2020)
8 South America Geriatric Medicine Revenue by Countries
8.1 South America Geriatric Medicine Revenue by Countries (2015-2020)
8.2 Brazil Geriatric Medicine Revenue and Growth Rate (2015-2020)
8.3 Argentina Geriatric Medicine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Geriatric Medicine by Countries
9.1 Middle East & Africa Geriatric Medicine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Geriatric Medicine Revenue and Growth Rate (2015-2020)
9.3 UAE Geriatric Medicine Revenue and Growth Rate (2015-2020)
9.4 Egypt Geriatric Medicine Revenue and Growth Rate (2015-2020)
9.5 South Africa Geriatric Medicine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Geriatric Medicine Revenue and Market Share by Type (2015-2020)
10.2 Global Geriatric Medicine Market Forecast by Type (2019-2024)
10.3 Analgesics Revenue Growth Rate (2015-2025)
10.4 Antihypertensives Revenue Growth Rate (2015-2025)
10.5 Statins Revenue Growth Rate (2015-2025)
10.6 Antidiabetics Revenue Growth Rate (2015-2025)
10.7 Proton Pump Inhibitor Revenue Growth Rate (2015-2025)
10.8 Anticoagulant Revenue Growth Rate (2015-2025)
10.9 Antipsychotic Revenue Growth Rate (2015-2025)
10.10 Antidepressant Revenue Growth Rate (2015-2025)
11 Global Geriatric Medicine Market Segment by Application
11.1 Global Geriatric Medicine Revenue Market Share by Application (2015-2020)
11.2 Geriatric Medicine Market Forecast by Application (2019-2024)
11.3 Cardiovascular Revenue Growth (2015-2020)
11.4 Arthritis Revenue Growth (2015-2020)
11.5 Neurological Revenue Growth (2015-2020)
11.6 Cancer Revenue Growth (2015-2020)
11.7 Osteoporosis Revenue Growth (2015-2020)
11.8 Respiratory Revenue Growth (2015-2020)
12 Global Geriatric Medicine Market Size Forecast (2021-2025)
12.1 Global Geriatric Medicine Market Size Forecast (2021-2025)
12.2 Global Geriatric Medicine Market Forecast by Regions (2021-2025)
12.3 North America Geriatric Medicine Revenue Market Forecast (2021-2025)
12.4 Europe Geriatric Medicine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Geriatric Medicine Revenue Market Forecast (2021-2025)
12.6 South America Geriatric Medicine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Geriatric Medicine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Geriatric Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Geriatric Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Geriatric Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Geriatric Medicine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Geriatric Medicine Major Business
Table 7. GSK Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Geriatric Medicine Product and Solutions
Table 10. GSK Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AstraZeneca Corporate Information, Location and Competitors
Table 12. AstraZeneca Geriatric Medicine Major Business
Table 13. AstraZeneca Geriatric Medicine Total Revenue (USD Million) (2018-2019)
Table 14. AstraZeneca SWOT Analysis
Table 15. AstraZeneca Geriatric Medicine Product and Solutions
Table 16. AstraZeneca Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Geriatric Medicine Major Business
Table 19. Bristol-Myers Squibb Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb SWOT Analysis
Table 21. Bristol-Myers Squibb Geriatric Medicine Product and Solutions
Table 22. Bristol-Myers Squibb Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 24. Boehringer Ingelheim Geriatric Medicine Major Business
Table 25. Boehringer Ingelheim Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 26. Boehringer Ingelheim SWOT Analysis
Table 27. Boehringer Ingelheim Geriatric Medicine Product and Solutions
Table 28. Boehringer Ingelheim Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Abbott Corporate Information, Location and Competitors
Table 30. Abbott Geriatric Medicine Major Business
Table 31. Abbott Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 32. Abbott SWOT Analysis
Table 33. Abbott Geriatric Medicine Product and Solutions
Table 34. Abbott Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Geriatric Medicine Major Business
Table 37. Novartis Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Geriatric Medicine Product and Solutions
Table 40. Novartis Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sanofi S.A. Corporate Information, Location and Competitors
Table 42. Sanofi S.A. Geriatric Medicine Major Business
Table 43. Sanofi S.A. Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 44. Sanofi S.A. SWOT Analysis
Table 45. Sanofi S.A. Geriatric Medicine Product and Solutions
Table 46. Sanofi S.A. Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Geriatric Medicine Major Business
Table 49. Eli Lilly Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Geriatric Medicine Product and Solutions
Table 52. Eli Lilly Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Geriatric Medicine Major Business
Table 55. Pfizer Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Geriatric Medicine Product and Solutions
Table 58. Pfizer Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck Corporate Information, Location and Competitors
Table 60. Merck Geriatric Medicine Major Business
Table 61. Merck Geriatric Medicine Total Revenue (USD Million) (2017-2018)
Table 62. Merck SWOT Analysis
Table 63. Merck Geriatric Medicine Product and Solutions
Table 64. Merck Geriatric Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Geriatric Medicine Revenue (Million USD) by Players (2015-2020)
Table 66. Global Geriatric Medicine Revenue Share by Players (2015-2020)
Table 67. Global Geriatric Medicine Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Geriatric Medicine Revenue Market Share by Regions (2015-2020)
Table 69. North America Geriatric Medicine Revenue by Countries (2015-2020)
Table 70. North America Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Table 71. Europe Geriatric Medicine Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Geriatric Medicine Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Geriatric Medicine Revenue by Countries (2015-2020)
Table 74. South America Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Geriatric Medicine Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Table 77. Global Geriatric Medicine Revenue (Million USD) by Type (2015-2020)
Table 78. Global Geriatric Medicine Revenue Share by Type (2015-2020)
Table 79. Global Geriatric Medicine Revenue Forecast by Type (2021-2025)
Table 80. Global Geriatric Medicine Revenue by Application (2015-2020)
Table 81. Global Geriatric Medicine Revenue Share by Application (2015-2020)
Table 82. Global Geriatric Medicine Revenue Forecast by Application (2021-2025)
Table 83. Global Geriatric Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Geriatric Medicine Picture
Figure 2. Global Geriatric Medicine Revenue Market Share by Type in 2019
Figure 3. Analgesics Picture
Figure 4. Antihypertensives Picture
Figure 5. Statins Picture
Figure 6. Antidiabetics Picture
Figure 7. Proton Pump Inhibitor Picture
Figure 8. Anticoagulant Picture
Figure 9. Antipsychotic Picture
Figure 10. Antidepressant Picture
Figure 11. Geriatric Medicine Revenue Market Share by Application in 2019
Figure 12. Cardiovascular Picture
Figure 13. Arthritis Picture
Figure 14. Neurological Picture
Figure 15. Cancer Picture
Figure 16. Osteoporosis Picture
Figure 17. Respiratory Picture
Figure 18. Global Geriatric Medicine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America Geriatric Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe Geriatric Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Geriatric Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America Geriatric Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa Geriatric Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Geriatric Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Geriatric Medicine Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Geriatric Medicine Revenue Market Share in 2019
Figure 27. Global Top 10 Players Geriatric Medicine Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global Geriatric Medicine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global Geriatric Medicine Revenue Market Share by Regions (2015-2020)
Figure 31. Global Geriatric Medicine Revenue Market Share by Regions in 2018
Figure 32. North America Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 33. Europe Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 35. South America Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 37. North America Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Figure 38. North America Geriatric Medicine Revenue Market Share by Countries in 2019
Figure 39. USA Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 40. Canada Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 41. Mexico Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 42. Europe Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Figure 43. Europe Geriatric Medicine Revenue Market Share by Countries in 2019
Figure 44. Germany Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 45. UK Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 46. France Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 47. Russia Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 48. Italy Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific Geriatric Medicine Revenue Market Share by Countries in 2019
Figure 51. China Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 52. Japan Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 53. Korea Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 54. India Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 56. South America Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Figure 57. South America Geriatric Medicine Revenue Market Share by Countries in 2019
Figure 58. Brazil Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 59. Argentina Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa Geriatric Medicine Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa Geriatric Medicine Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 63. UAE Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 64. Egypt Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 65. South Africa Geriatric Medicine Revenue and Growth Rate (2015-2020)
Figure 66. Global Geriatric Medicine Revenue Share by Type (2015-2020)
Figure 67. Global Geriatric Medicine Revenue Share by Type in 2019
Figure 68. Global Geriatric Medicine Market Share Forecast by Type (2021-2025)
Figure 69. Global Analgesics Revenue Growth Rate (2015-2020)
Figure 70. Global Antihypertensives Revenue Growth Rate (2015-2020)
Figure 71. Global Statins Revenue Growth Rate (2015-2020)
Figure 72. Global Antidiabetics Revenue Growth Rate (2015-2020)
Figure 73. Global Proton Pump Inhibitor Revenue Growth Rate (2015-2020)
Figure 74. Global Anticoagulant Revenue Growth Rate (2015-2020)
Figure 75. Global Antipsychotic Revenue Growth Rate (2015-2020)
Figure 76. Global Antidepressant Revenue Growth Rate (2015-2020)
Figure 77. Global Geriatric Medicine Revenue Share by Application (2015-2020)
Figure 78. Global Geriatric Medicine Revenue Share by Application in 2019
Figure 79. Global Geriatric Medicine Market Share Forecast by Application (2021-2025)
Figure 80. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 81. Global Arthritis Revenue Growth Rate (2015-2020)
Figure 82. Global Neurological Revenue Growth Rate (2015-2020)
Figure 83. Global Cancer Revenue Growth Rate (2015-2020)
Figure 84. Global Osteoporosis Revenue Growth Rate (2015-2020)
Figure 85. Global Respiratory Revenue Growth Rate (2015-2020)
Figure 86. Global Geriatric Medicine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global Geriatric Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global Geriatric Medicine Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America Geriatric Medicine Revenue Market Forecast (2021-2025)
Figure 90. Europe Geriatric Medicine Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific Geriatric Medicine Revenue Market Forecast (2021-2025)
Figure 92. South America Geriatric Medicine Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa Geriatric Medicine Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
AYUSH及び代替医療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global AYUSH and Alternative Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AYUSH and Alte…- 職業病用医薬品の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Occupational Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Occupational Medicine m…
- にきび治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Acne Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acne Medicine market report pro…
- アレルギー用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Allergy Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergy Medicine market repo…
- デジタル医学の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Digital Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3726.6 million by 2025, from USD 2420.2 million in 2019. The Digital Medicine m…